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Abstract 
Objective: Test the diagnostic performance of a comprehensive set of tests and measures to discriminate 
patellofemoral (PF) from tibiofemoral (TF) osteoarthritis (OA).  
Methods: The Clinical Assessment of the Knee Study is a study of knee pain in the general population. The 
presence of PF crepitus and pain with PF compression were assessed. Anterior knee pain (AKP) was 
determined from a knee pain map.  Pain with stairs and walking on level ground were assessed with the 
WOMAC. Radiographs were used to define the compartment(s) of the knee affected by OA as: no OA, 
isolated/predominant PF OA, and isolated/predominant TF OA. In knees with mixed OA, knees with more 
severe PF OA were included in the isolated/predominant PF group (the same was done for TF OA). We 
determined the sensitivity (Sn), specificity (Sp), positive and negative predictive values (PPV and NPV), and 
positive likelihood ratio (LR+) for each test and measure individually, and the combination of these measures, 
in identifying knees with PF OA from knees with TFJ OA or no OA.  
Results: 745 knees were included in the study. No measure had high Sn and Sp. Pain with stairs had the 
greatest Sn (90%) but poor Sp (15%). The combination of definite crepitus with no pain on walking had the 
greatest Sp (96%), PPV (53%) and LR+ (1.8) but poor Sn (7%).  
Conclusions: Typical clinical examination findings and knee pain patterns commonly thought to represent 
underlying PF pathology do not discriminate knees with PF OA from knees without OA or TF OA. 
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 Significance and Innovation 
 In order to maximize targeted/individualized care and recruit for trials, clinicians/researchers need to be 
able to discriminate between knees with patellofemoral and tibiofemoral osteoarthritis 
 No diagnostic test assessed had a high sensitivity and specificity in discriminating isolated/predominant 
patellofemoral joint osteoarthritis from those with isolated/predominant tibiofemoral joint 
osteoarthritis/no osteoarthritis 
 Pain with stairs had the greatest sensitivity (90%) but poor specificity (15%) 
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Knee osteoarthritis (OA) can affect the patellofemoral joint (PFJ) and/or the tibiofemoral joint (TFJ). 
Contrary to common belief, the PFJ may be a more common site of OA (1, 2) and source of symptoms (3, 4) 
than OA in the TFJ. PFJ OA also predicts the incidence of TFJ OA (5, 6). Despite this, there is limited evidence 
for rehabilitation approaches (e.g., bracing, taping, foot orthoses, strengthening, etc.) to decrease pain and 
improve function in those with PFJ OA. Biomechanical and rehabilitation treatments for PFJ and TFJ OA likely 
differ. Thus, it would be helpful to discriminate individuals with PFJ OA from those with TFJ OA from clinical 
examination findings and clinically important pain patterns. Further, to enroll individuals in clinical trials, and 
avoid the cost of using imaging to screen potential participants, a simple method is needed to discriminate those 
with PFJ OA from those with TFJ OA. 
Anterior knee pain (AKP) and pain ascending and descending stairs are widely believed to be indicative 
of PFJ pathology. However, we previously reported that these self-reported pain measures have poor diagnostic 
utility to identify MRI-defined PFJ OA in a large cohort study of older individuals (7). It is possible that the 
combination of objective clinical examination measures in addition to location of pain and pain with activities 
will improve the ability to discriminate individuals with PFJ OA from those with TFJ OA. Crepitus (i.e., an 
audible cracking or grinding with movement of a joint) is associated with MRI features of OA in the PFJ but not 
the TFJ (8, 9).  Additionally, a PFJ compression/glide test may be indicative PFJ pathology. 
While there is an increasing body of evidence on the relevance to symptoms of MRI-detected lesions of 
cartilage and bone in the PFJ (10), abnormalities detected by this imaging modality are common in 
asymptomatic older adults (11). Plain radiographs are less sensitive but evidence of radiographic PFJ OA is 
associated with knee pain and functional limitations (3), and remains the more common imaging procedure in 
routine clinical practice. It is important to know if common tests and measures thought to be related to PFJ OA 
can be used as diagnostic tests to identify individuals with radiographic PFJ OA. 
The purpose of the current study was to test a comprehensive set of diagnostic tests and measures to 
discriminate patellofemoral (PF) from tibiofemoral (TF) osteoarthritis (OA) and see if, in doing so, we could 
improve upon a previous study (7) which used MRI diagnosis and a more limited set of diagnostic tests.  
Patients and Methods 
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The Clinical Assessment of the Knee (CAS-K) Study is a large prospective study of knee pain in the 
general population in North Staffordshire, United Kingdom (12) . Baseline data was collected from 2002-2003 
and all participants were 50 years and over with knee pain. Potential participants were recruited by postal 
survey and those reporting pain around the knee in the past 12 months were invited to participate in the study. 
The study protocol was approved by the North Staffordshire Local Research Ethics Committee (project number 
1430). Details of the study have been previously published (12).  
Clinical Tests and Measures 
Details of the methods for clinical tests and measures used in the current study have been described in detail 
previously (13). Briefly, three research physical therapists based at an academic center for primary care research 
with 7, 9, and 10 years of experience performed all measures. They were trained in the standardized physical 
examination with a manual for reference with detailed protocols. Feedback was given during training from two 
specialist musculoskeletal clinicians. Inter-reader reliability (kappa value) was 0.53 and 0.54 for crepitus and 
PFJ compression respectively. Coarse crepitus was assessed with the participants positioned sitting on the edge 
of an adjustable table so the participants’ knees were flexed to 90º with both feet on the floor. With the hand 
over the PFJ, participants were instructed to stand up slowly, putting weight evenly through both legs. The 
examiner palpated for coarse crepitus under the patella as they rose and then sat back down. Crepitus was 
graded as none, possible, or definite. A PFJ glide/compression test was performed with participants positioned 
half-lying on a table with a pillow behind both knees. The examiner gently applied compression to their PFJ, 
ensuring no mediolateral or caudad/cephalad movement of the patella. Subjects were asked if the maneuver was 
painful. If there was no pain, compression was applied with a glide of the patella inferiorly as far as it would go, 
releasing the compressive force once the patella returned to its resting position. The subject was then asked 
again if the maneuver was painful. Pain was recorded as: none, pain with glide, or pain with compression. 
Assessment of Knee Pain 
Knee pain map: A knee pain map was used by participants to identify painful areas around the knee (14). 
Participants were asked to indicate on their own knees ‘‘where your knee hurts.’’ Painful areas indicated by 
participants were shaded by an assessor on a pre-drawn manikin. A transparent template, with the boundaries 
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for all 13 sites marked on it, was laid over the completed manikins. Any shading in a site was recorded as 
‘present’. AKP was considered to be present if pain was present in the prepatellar or infrapatellar regions. 
Knee pain with activities: Participants reported pain with ascending or descending stairs and walking on level 
ground (its absence might rule in PFJ pathology) using the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC). Pain was rated as none, mild, moderate, severe, or extreme. 
Radiographic Assessment of Knee OA 
Radiographs were obtained and read of the most painful knee. If both knees were painful, one knee was 
selected at random. Three views of the knee were obtained for each subject: weight-bearing semi-flexed 
postero-anterior (PA), supine skyline, and lateral views. A Kellgren and Lawrence (KL) score was assigned to 
the PA and skyline views. TFJ OA was defined by a KL score ≥2 on the PA view and/or the presence of 
definite osteophytes on the posterior tibial surface of the lateral view. PFJ OA was defined by a KL score ≥2 on 
the skyline view and/or the presence of a definite superior and/or inferior osteophyte on the patellar surface of 
the lateral view using a standard atlas (1). Inter-observer reliability for KL scores and osteophytes for the PFJ 
and TFJ ranged from 0.49-0.76 (unweighted kappa) (1). We categorized knees into having no OA, isolated PFJ 
OA, isolated TFJ OA, and mixed PFJ/TFJ OA. In knees with mixed PFJ/TFJ OA, we then determined which 
compartment had the greatest OA severity. Knees with more severe PFJ OA were considered to have 
isolated/predominant PFJ OA (the same was done for isolated/predominant TFJ OA). If the severity of OA was 
the same in the PFJ and TFJ, these knees were removed from the study.  
Statistical Analysis 
We determined the sensitivity (Sn), specificity (Sp), positive and negative predictive values (PPV and 
NPV), and positive likelihood ratio (LR+; Sn/1-Sp) for PFJ compression test, PFJ crepitus, AKP, pain with 
stairs (≥ mild), absence of pain with walking (≤ mild), and the combination of these measures in discriminating 
knees with isolated/predominant PFJ OA from knees with isolated/predominant TFJ OA or no OA. In 
sensitivity analyses we used a KL score ≥3 (moderate OA) to define PFJ and TFJ OA. We additionally 
performed analyses removing all knees with mixed OA using both a KL score ≥2 and ≥3 as our OA definitions. 
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We compared knees with isolated PFJ OA to those with no OA, and compared knees with isolated PFJ OA to 
those with isolated TFJ OA.  
Results 
745 knees (one knee per person) were included in the study. The mean (sd) age was 65.2 (8.6) and mean 
BMI was 29.6 (5.2); 55% were female (Table 1). The prevalence of no OA, isolated PFJ OA, isolated TFJ OA, 
and mixed was 236 (32%), 178 (24%), 30 (4%) and 301 (40%), respectively. Of 301 knees with mixed OA, 57 
and 115 had more severe PFJ and TFJ OA, respectively; 129 had the same severity and were removed from our 
primary analysis. This left 616 knees eligible for our primary analysis; 381 with no OA or isolated/predominant 
TFJ OA and 235 with isolated/predominant PFJ OA. Those in the isolated/predominant PFJ OA group were 
slightly older with higher BMIs and were more likely to be male (Table 1). 
The most common diagnostic test measures were pain with stairs (492/566; 87%) and presence of AKP 
(414/574; 72%) (Table 2); the least common was isolated AKP (48/574; 8%). No measure had high Sn and Sp 
(Table 2). Pain with stairs had the greatest Sn (90%) but poor Sp (15%). The combination of definite crepitus 
with no pain with walking had the greatest Sp (96%), PPV (53%) and LR+ (1.8) but poor Sn (7%). No test or 
combination of test had a LR+ greater than 2.  
Using the moderate definition of OA, the prevalence of no OA, isolated PFJ OA, isolated TFJ OA, and 
mixed was 453 (61%), 99 (13%), 123 (17%) and 70 (9%), respectively. All 70 knees with mixed OA had the 
same severity in the PFJ and TFJ and were removed from the analysis. This left 675 knees eligible for the 
sensitivity analysis; 576 with no OA or isolated TFJ OA, and 99 with isolated PFJ OA. When using a moderate 
definition of OA, no measure had high Sn and Sp (Table 3). In general, Sn and Sp remained unchanged, while 
PPV decreased and NPV increased compared to results when using a mild OA definition. The combination of 
definite crepitus with AKP, pain with stairs, and no pain with walking all had LR+ greater than 2. Results 
comparing knees with isolated PFJ OA to those with no OA and comparing knees with isolated PFJ OA to those 
with isolated TFJ OA are presented in supplemental tables 1-4. We see a similar pattern in these results as in 
our main analyses with no test having a high Sn and SP, and in general test combinations that include crepitus 
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having the greatest LR+. The exception to this was in the comparison of isolated moderate PFJ OA to isolated 
moderate TFJ OA, pain with compression + no pain with walking had the greatest LR+ (2.8). 
Discussion 
In order to recruit individuals for clinical trials and to prescribe the most effective interventions for 
individuals with PFJ or TFJ OA, clinicians and researchers need to be able to discriminate between these two 
phenotypes of knee OA.  We found that among persons aged over 50 years with knee pain, typical clinical 
examination findings and knee pain patterns (pain location and with activities) that are commonly thought to 
represent underlying PFJ pathology do not discriminate knees with PFJ OA from TFJ OA/no OA. The results of 
the current study are consistent with our previous studies in the MOST cohort using MRI criteria for knee OA 
and pain location and with activities (7) and with Peat et al. (15). Using radiography with both a lateral and 
skyline view to diagnose PFJ OA (1), and also adding objective measures from a clinical examination, we found 
no test with a LR+ greater than 2. It was hypothesized that adding objective measures from the clinical 
examination may improve our ability to discriminate those with PFJ OA from those with TFJ OA/no OA. 
However, when using moderate severity as an OA definition, definite crepitus combined with AKP, pain with 
stairs, and no pain with walking all had LR+ greater than 2. Similar results were also seen when removing knees 
with mixed OA (supplemental tables). However, we would caution the interpretation of these results, as they do 
not replicate what is typically seen in a clinical or research recruitment setting. In these settings, we cannot 
exclude these individuals; and, we need to be able to identify those with primary PFJ OA from all those with 
knee pain that may or may not have TFJ involvement.   
Contrary to our findings, others have found a relationship between crepitus and PFJ MRI features of 
OA. Schiphof et al. found among females without OA, using a proposed MRI definition, that the presence of 
crepitus was associated with cartilage damage (odds ratio (OR): 5.5 (95% confidence interval (CI) 3.8-7.9), 
osteophytes (OR: 2.6 (2.0-3.4), cysts (OR: 2.8 (2.0-4.0), and bone marrow lesions (OR: 3.7 (2.7-5.0) in the PFJ 
(9). They also found a relation between a history of patellar pain and all the above features except osteophytes. 
No relation was found between crepitus and patellar pain with these features in the TFJ. The post-test 
probabilities of crepitus, patellar pain and the combination of the two were 64.3, 54.7 and 71.8%, respectively. 
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However, Crema et al. found a relationship between crepitus and osteophytes in both the PFJ and TFJ (8).  
While these previous studies report an association between crepitus and PFJ OA, we found crepitus to have low 
sensitivity (24%), and high specificity (82%). This highlights the need to be cautious in using crepitus as a 
diagnostic indicator of mild PFJ OA, despite high odds ratios for the association between crepitus and PFJ OA 
features on MRI. However, using a moderate definition of OA, the greatest positive likelihood ratios were 
found when crepitus was combined with anterior knee pain, pain with stairs, and no pain with walking. 
Consistent with our results, Schiphof et al. also found no relation between a patellar compression test and PFJ 
OA features on MRI. 
Our findings highlight the need for improved understanding of knee pain pathophysiology and ways to 
appropriately target compartment-specific biomechanical or rehabilitation interventions in OA. When recruiting 
participants for clinical trials for PFJ OA, researchers need to be cautious in the tests and measures that are used 
for recruitment strategies. Based on the results of the current study, definite crepitus combined with no pain 
with walking has the lowest false positive rate (4%; Sp=96%). Using this combination will most likely yield 
participants that actually have PFJ OA. Further research is needed to determine the best recruitment strategies 
for PFJ trials. It is recommended that investigators who recruit subjects with PFJ OA publish detailed 
information on their recruitment strategies and the % yield (e.g., those that met inclusion criteria that actually 
had PFJ OA). 
 We recognize limitations to our current study. While lateral and skyline radiographs identify the most 
cases of PFJ OA (1), it may not detect early OA changes seen on MRI. Despite this, we find similar results to a 
previous study using MRI criteria to define PFJ and TFJ OA. Additionally, MRI may be too sensitive and the 
clinical significance of early MRI lesions is unknown. Also, evidence of changes on imaging may represent 
historic joint damage, which may no longer be relevant to symptoms, and this remains a challenge for 
diagnostic studies in OA. We recognize pain is a subjective experience that varies greatly between individuals 
and is influenced by psychosocial factors for which we did not account. However, in performing analyses 
evaluating diagnostic tests, we hoped to replicate how simple tests may be used by clinicians in order to 
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diagnose PFJ OA. We do recognize that the reliability of clinical exam measures may influence our results as 
misclassification of exam measures may occur (13).  
 In summary, typical clinical exam findings and knee pain patterns commonly thought to represent 
underlying PF pathology do not discriminate knees with PF OA from knees without OA or TF OA. Clinicians 
and researchers should be cautious using these clinical tests and measures to identify individuals with PFJ OA, 
both in an everyday clinical setting or in a research setting when defining PFJ OA. 
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Table 1. Baseline characteristics 
 All knees (n=745) Isolated/predominant 
PFJ OA (n=235) 
Isolated/predominant TFJ OA 
and no OA (n=381) 
Mean Age, years 65.2 (8.6) 65.9 (8.8) 64.3 (8.5) 
Sex (% female) 55 48.9 59.1 
Mean BMI, kg/m
2
 29.6 (5.2) 29.6 (4.7) 29.1 (5.1) 
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Table 2. Diagnostic utility of clinical examination measures, location of pain and pain with activities to identify knees with 
isolated/predominant mild PFJ OA (compared to knees with no OA and isolated/predominant mild TFJ OA) 
 Prevalence* Sensitivity Specificity PPV NPV LR+ 
Clinical Exam Measures        
Definite crepitus 123/616 (20%) 24% 82% 46% 64% 1.3 
Pain with PFJ compression 308/615 (50%) 56% 53% 43% 66% 1.2 
Knee Pain Location        
AKP 414/574 
(72%) 
74% 29% 39% 64% 1.0 
Isolated AKP 48/574 
(8%) 
10% 92% 44% 62% 1.3 
Pain with Activities        
Pain with stairs 492/566 (87%) 90% 15% 40% 70% 1.1 
No pain with walking 168/571 
(29%) 
26% 69% 35% 60% 0.8 
Combined Measures        
Definite crepitus + AKP 94/574 
(16%) 
20% 86% 46% 63% 1.4 
Pain with PFJ compression + AKP 219/574 (38%) 43% 65% 43% 65% 1.2 
Definite crepitus + pain with stairs 105/566 (19%) 23% 84% 48% 63% 1.4 
Pain with PFJ compression + pain 
with stairs 
261/565 
(46%) 
52% 58% 44% 65% 1.2 
Definite crepitus + no pain with 
walking 
30/571 
(5%) 
7% 96% 53% 62% 1.8 
Pain with PFJ compression + no 
pain with walking 
50/570 
(9%) 
10% 92% 42% 62% 1.3 
AKP + pain with stairs 339/528 
(64%) 
67% 38% 40% 65% 1.1 
AKP + no pain with walking 105/534 
(20%) 
20% 81% 39% 62% 1.1 
*Denominators vary based on missing data for clinical exam and pain measures 
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Table 3. Diagnostic utility of clinical examination measures, location of pain and pain with activities to identify knees with 
isolated moderate PFJ OA (compared to knees with no OA and isolated moderate TJF OA) 
 Prevalence* Sensitivity Specificity PPV NPV LR+ 
Clinical Exam Measures        
Definite crepitus 132/675 (20%) 33% 83% 25% 88% 1.9 
Pain with PFJ compression 336/674 (50%) 70% 54% 21% 91% 1.5 
Knee Pain Location        
AKP 455/630 
(72%) 
77% 29% 16% 87% 1.1 
Isolated AKP 55/630 
(9%) 
6% 91% 11% 84% 0.7 
Pain with Activities        
Pain with stairs 542/622 (87%) 92% 14% 16% 91% 1.1 
No pain with walking 186/627 
(30%) 
24% 69% 12% 84% 0.8 
Combined Measures        
Definite crepitus + AKP 99/630 
(16%) 
28% 87% 27% 87% 2.2 
Pain with PFJ compression + AKP 239/630 
(38%) 
53% 65% 21% 88% 1.5 
Definite crepitus + pain with stairs 112/622 (18%) 34% 85% 28% 88% 2.3 
Pain with PFJ compression + pain 
with stairs 
286/621 
(46%) 
67% 58% 21% 91% 1.6 
Definite crepitus + no pain with 
walking 
34/627 
(5%) 
10% 95% 26% 86% 2.0 
Pain with PFJ compression + no 
pain with walking 
57/626 
(9%) 
11% 91% 18% 85% 1.2 
AKP + pain with stairs 377/583 
(64%) 
72% 37% 17% 88% 1.1 
AKP + no pain with walking 118/589 
(20%) 
20% 80% 15% 85% 1.0 
*Denominators vary based on missing data for clinical exam and pain measures 
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